Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 513

1.

Live-cell based assays are the gold standard for anti-MOG-Ab testing.

Yeh EA, Nakashima I.

Neurology. 2019 Feb 6. pii: 10.1212/WNL.0000000000007077. doi: 10.1212/WNL.0000000000007077. [Epub ahead of print] No abstract available.

PMID:
30728306
2.

Clinical significance of assaying anti-MOG antibody in cerebrospinal fluid in MOG-antibody-associated diseases: A case report.

Aoe S, Kume K, Takata T, Touge T, Kaneko K, Nakashima I, Deguchi K, Masaki T.

Mult Scler Relat Disord. 2018 Dec 29;28:165-166. doi: 10.1016/j.msard.2018.12.035. [Epub ahead of print]

PMID:
30605793
3.

Circulating AQP4-specific auto-antibodies alone can induce neuromyelitis optica spectrum disorder in the rat.

Hillebrand S, Schanda K, Nigritinou M, Tsymala I, Böhm D, Peschl P, Takai Y, Fujihara K, Nakashima I, Misu T, Reindl M, Lassmann H, Bradl M.

Acta Neuropathol. 2018 Dec 18. doi: 10.1007/s00401-018-1950-8. [Epub ahead of print]

PMID:
30564980
4.

Influence of Nutritional Management and Rehabilitation on Physical Outcome in Japanese Intensive Care Unit Patients: A Multicenter Observational Study.

Yatabe T, Egi M, Sakaguchi M, Ito T, Inagaki N, Kato H, Kaminohara J, Konishi A, Takahashi M, Tatsumi H, Tobe M, Nakashima I, Nakamoto N, Nishimura T, Nitta M, Nishimura M.

Ann Nutr Metab. 2019;74(1):35-43. doi: 10.1159/000495213. Epub 2018 Dec 12.

PMID:
30541003
5.

Clinical spectrum of inflammatory central nervous system demyelinating disorders associated with antibodies against myelin oligodendrocyte glycoprotein.

Akaishi T, Sato DK, Takahashi T, Nakashima I.

Neurochem Int. 2018 Oct 23. pii: S0197-0186(18)30404-2. doi: 10.1016/j.neuint.2018.10.016. [Epub ahead of print] Review.

PMID:
30365980
6.

Surgical techniques for advanced transverse colon cancer using the pincer approach of the transverse mesocolon.

Egi H, Nakashima I, Hattori M, Mukai S, Kochi M, Taguchi K, Sada H, Sumi Y, Ohdan H.

Surg Endosc. 2019 Feb;33(2):639-643. doi: 10.1007/s00464-018-6491-7. Epub 2018 Oct 23.

PMID:
30353241
7.

Abnormal Osmolality Gap Exists in Distal Symmetric Polyneuropathy.

Akaishi T, Takahashi T, Nakashima I, Aoki M.

Tohoku J Exp Med. 2018 Sep;246(1):59-64. doi: 10.1620/tjem.246.59.

8.

A case of ascending colon cancer accompanied with tumor thrombosis in the superior mesenteric vein treated with right hemicolectomy and greater saphenous vein grafting.

Akabane S, Mukai S, Egi H, Adachi T, Kochi M, Sato K, Sumi Y, Nakashima I, Taguchi K, Sada H, Ishikawa A, Yasui W, Ohdan H.

Int J Surg Case Rep. 2018;51:358-363. doi: 10.1016/j.ijscr.2018.09.007. Epub 2018 Sep 9.

9.

Area postrema syndrome: Frequency, criteria, and severity in AQP4-IgG-positive NMOSD.

Shosha E, Dubey D, Palace J, Nakashima I, Jacob A, Fujihara K, Takahashi T, Whittam D, Leite MI, Misu T, Yoshiki T, Messina S, Elsone L, Majed M, Flanagan E, Gadoth A, Huebert C, Sagen J, Greenberg BM, Levy M, Banerjee A, Weinshenker B, Pittock SJ.

Neurology. 2018 Oct 23;91(17):e1642-e1651. doi: 10.1212/WNL.0000000000006392. Epub 2018 Sep 26.

10.

Extranodal NK/T-cell Lymphoma Mimicking Granulomatous Myositis.

Kawaguchi N, Izumi R, Kobayashi M, Tateyama M, Suzuki N, Fujishima F, Fujimori J, Aoki M, Nakashima I.

Intern Med. 2019 Jan 15;58(2):277-282. doi: 10.2169/internalmedicine.0859-18. Epub 2018 Aug 24.

11.

Visual prognosis in seronegative idiopathic optic neuritis finally elucidated: as bad as that in anti-AQP4 antibody-positive optic neuritis.

Akaishi T, Nakashima I.

Eur J Neurol. 2018 Nov;25(11):1305-1306. doi: 10.1111/ene.13772. Epub 2018 Aug 28. No abstract available.

PMID:
30103293
12.

MOG-IgG-associated disease has a stereotypical clinical course, asymptomatic visual impairment and good treatment response.

Pandit L, Mustafa S, Nakashima I, Takahashi T, Kaneko K.

Mult Scler J Exp Transl Clin. 2018 Jul 17;4(3):2055217318787829. doi: 10.1177/2055217318787829. eCollection 2018 Jul-Sep.

13.

CSF cytokine profile in MOG-IgG+ neurological disease is similar to AQP4-IgG+ NMOSD but distinct from MS: a cross-sectional study and potential therapeutic implications.

Kaneko K, Sato DK, Nakashima I, Ogawa R, Akaishi T, Takai Y, Nishiyama S, Takahashi T, Misu T, Kuroda H, Tanaka S, Nomura K, Hashimoto Y, Callegaro D, Steinman L, Fujihara K, Aoki M.

J Neurol Neurosurg Psychiatry. 2018 Sep;89(9):927-936. doi: 10.1136/jnnp-2018-317969. Epub 2018 Jun 6.

14.

Myelin Oligodendrocyte Glycoprotein-IgG-positive Recurrent Bilateral Optic Papillitis with Serous Retinal Detachment.

Kon T, Hikichi H, Ueno T, Suzuki C, Nunomura J, Kaneko K, Takahashi T, Nakashima I, Tomiyama M.

Intern Med. 2018 Nov 15;57(22):3307-3312. doi: 10.2169/internalmedicine.9840-17. Epub 2018 May 18.

15.

Fingolimod-associated PML with mild IRIS in MS: A clinicopathologic study.

Nishiyama S, Misu T, Shishido-Hara Y, Nakamichi K, Saijo M, Takai Y, Takei K, Yamamoto N, Kuroda H, Saito R, Watanabe M, Tominaga T, Nakashima I, Fujihara K, Aoki M.

Neurol Neuroimmunol Neuroinflamm. 2017 Nov 10;5(1):e415. doi: 10.1212/NXI.0000000000000415. eCollection 2018 Jan.

16.

Peripheral blood monocyte count at onset may affect the prognosis in multiple sclerosis.

Akaishi T, Takahashi T, Nakashima I.

J Neuroimmunol. 2018 Jun 15;319:37-40. doi: 10.1016/j.jneuroim.2018.03.016. Epub 2018 Mar 27.

PMID:
29685288
17.

Chaos theory for clinical manifestations in multiple sclerosis.

Akaishi T, Takahashi T, Nakashima I.

Med Hypotheses. 2018 Jun;115:87-93. doi: 10.1016/j.mehy.2018.04.004. Epub 2018 Apr 11.

PMID:
29685206
18.

Human central nervous system astrocytes support survival and activation of B cells: implications for MS pathogenesis.

Touil H, Kobert A, Lebeurrier N, Rieger A, Saikali P, Lambert C, Fawaz L, Moore CS, Prat A, Gommerman J, Antel JP, Itoyama Y, Nakashima I, Bar-Or A; Canadian B Cell Team in MS.

J Neuroinflammation. 2018 Apr 19;15(1):114. doi: 10.1186/s12974-018-1136-2.

19.

Rituximab was effective for acute disseminated encephalomyelitis followed by recurrent optic neuritis with anti-myelin oligodendrocyte glycoprotein antibodies.

Nagashima M, Osaka H, Ikeda T, Matsumoto A, Miyauchi A, Kaneko K, Nakashima I, Nakano Y, Wakabayashi K, Monden Y, Yamagata T.

Brain Dev. 2018 Aug;40(7):607-611. doi: 10.1016/j.braindev.2018.03.011. Epub 2018 Apr 13.

PMID:
29661590
20.

[Autoantibodies in Neuromyelitis Optica Spectrum Disorders].

Nakashima I, Akaishi T.

Brain Nerve. 2018 Apr;70(4):297-304. doi: 10.11477/mf.1416201003. Japanese.

PMID:
29632278
21.

Chloride imbalance is involved in the pathogenesis of optic neuritis in neuromyelitis optica.

Akaishi T, Takahashi T, Himori N, Takeshita T, Nakazawa T, Aoki M, Nakashima I.

J Neuroimmunol. 2018 Jul 15;320:98-100. doi: 10.1016/j.jneuroim.2018.03.010. Epub 2018 Mar 16.

PMID:
29572032
22.

Oligoclonal bands and periventricular lesions in multiple sclerosis will not increase blood-brain barrier permeability.

Akaishi T, Takahashi T, Nakashima I.

J Neurol Sci. 2018 Apr 15;387:129-133. doi: 10.1016/j.jns.2018.02.020. Epub 2018 Feb 6.

PMID:
29571849
23.

Spontaneous Recanalization of the Obstructed Right Coronary Artery Caused by Blunt Chest Trauma.

Haraguchi Y, Sakakura K, Yamamoto K, Taniguchi Y, Nakashima I, Wada H, Sanui M, Momomura SI, Fujita H.

Int Heart J. 2018 Mar 30;59(2):407-412. doi: 10.1536/ihj.17-173. Epub 2018 Feb 23.

24.

CV2/CRMP5-antibody-related Paraneoplastic Optic Neuropathy Associated with Small-cell Lung Cancer.

Nakajima M, Uchibori A, Ogawa Y, Miyazaki T, Ichikawa Y, Kaneko K, Takahashi T, Nakashima I, Shiraishi H, Motomura M, Chiba A.

Intern Med. 2018 Jun 1;57(11):1645-1649. doi: 10.2169/internalmedicine.9736-17. Epub 2018 Jan 11.

25.

Chloride imbalance between serum and CSF in the acute phase of neuromyelitis optica.

Akaishi T, Takahashi T, Nakashima I.

J Neuroimmunol. 2018 Feb 15;315:45-49. doi: 10.1016/j.jneuroim.2017.12.019. Epub 2017 Dec 21.

PMID:
29306405
26.

Cognitive impairment in neuromyelitis optica spectrum disorders: A comparison of the Wechsler Adult Intelligence Scale-III and the Wechsler Memory Scale Revised with the Rao Brief Repeatable Neuropsychological Battery.

Fujimori J, Nakashima I, Baba T, Meguro Y, Ogawa R, Fujihara K.

eNeurologicalSci. 2017 Sep 21;9:3-7. doi: 10.1016/j.ensci.2017.09.001. eCollection 2017 Dec.

27.
28.

[Anti-MOG Antibody Associated Diseases].

Nakashima I.

Brain Nerve. 2017 Nov;69(11):1331-1336. doi: 10.11477/mf.1416200912. Review. Japanese.

PMID:
29172198
29.

Subclinical retinal atrophy in the unaffected fellow eyes of multiple sclerosis and neuromyelitis optica.

Akaishi T, Kaneko K, Himori N, Takeshita T, Takahashi T, Nakazawa T, Aoki M, Nakashima I.

J Neuroimmunol. 2017 Dec 15;313:10-15. doi: 10.1016/j.jneuroim.2017.10.001. Epub 2017 Oct 3.

PMID:
29153600
30.

Reversible paraspinal muscle hyperintensity in anti-MOG antibody-associated transverse myelitis.

Pandit L, Mustafa S, Uppoor R, Nakashima I, Takahashi T, Kaneko K.

Neurol Neuroimmunol Neuroinflamm. 2017 Oct 27;5(1):e412. doi: 10.1212/NXI.0000000000000412. eCollection 2018 Jan. No abstract available.

31.

[A case of recurrent myelitis associated with anti-myelin oligodendrocyte glycoprotein antibody that developed only as localized short spinal cord lesions].

Matsumoto A, Kaneko K, Takahashi T, Nakashima I, Hisanaga K, Nagano I.

Rinsho Shinkeigaku. 2017 Nov 25;57(11):729-732. doi: 10.5692/clinicalneurol.cn-001014. Epub 2017 Oct 26. Japanese.

PMID:
29070750
32.

A case of MOG antibody-positive bilateral optic neuritis and meningoganglionitis following a genital herpes simplex virus infection.

Nakamura M, Iwasaki Y, Takahashi T, Kaneko K, Nakashima I, Kunieda T, Kaneko S, Kusaka H.

Mult Scler Relat Disord. 2017 Oct;17:148-150. doi: 10.1016/j.msard.2017.07.023. Epub 2017 Jul 27.

PMID:
29055448
33.

Prevalence and clinical features of neuromyelitis optica spectrum disorders in northern Japan.

Houzen H, Kondo K, Niino M, Horiuchi K, Takahashi T, Nakashima I, Tanaka K.

Neurology. 2017 Nov 7;89(19):1995-2001. doi: 10.1212/WNL.0000000000004611. Epub 2017 Oct 6.

PMID:
28986408
34.

Efficiency of antibody therapy in demyelinating diseases.

Akaishi T, Nakashima I.

Int Immunol. 2017 Jul 1;29(7):327-335. doi: 10.1093/intimm/dxx037. Review.

PMID:
28910968
35.

Is MOG-IgG another biomarker for neuromyelitis optica?

Nakashima I.

J Neurol Neurosurg Psychiatry. 2017 Oct;88(10):807. doi: 10.1136/jnnp-2017-316247. Epub 2017 Jul 6. No abstract available.

PMID:
28684533
36.

Clinical features in very early-onset demyelinating disease with anti-MOG antibody.

Nishiyama M, Nagase H, Matsumoto M, Tomioka K, Awano H, Tanaka T, Toyoshima D, Fujita K, Maruyama A, Oyazato Y, Saeki K, Shiraishi K, Takada S, Kaneko K, Takahashi T, Nakashima I, Iijima K.

Brain Dev. 2017 Oct;39(9):756-762. doi: 10.1016/j.braindev.2017.05.004. Epub 2017 May 24.

PMID:
28551039
37.

Foveal thinning in neuromyelitis optica: A sign of retinal astrocytopathy?

Yamamura T, Nakashima I.

Neurol Neuroimmunol Neuroinflamm. 2017 Apr 11;4(3):e347. doi: 10.1212/NXI.0000000000000347. eCollection 2017 May. No abstract available.

38.

Anti-MOG antibody-positive ADEM following infectious mononucleosis due to a primary EBV infection: a case report.

Nakamura Y, Nakajima H, Tani H, Hosokawa T, Ishida S, Kimura F, Kaneko K, Takahashi T, Nakashima I.

BMC Neurol. 2017 Apr 19;17(1):76. doi: 10.1186/s12883-017-0858-6.

39.

Successful treatment of nonocclusive mesenteric ischemia after aortic valve replacement with continuous arterial alprostadil infusion: A case report.

Ogi K, Sanui M, Iizuka Y, Aomatsu A, Nakashima I, Hamamoto K, Okochi T, Lefor AK.

Int J Surg Case Rep. 2017;35:8-11. doi: 10.1016/j.ijscr.2017.03.037. Epub 2017 Mar 30.

40.

Neuromyelitis Optica Spectrum Disorders.

Akaishi T, Nakashima I, Sato DK, Takahashi T, Fujihara K.

Neuroimaging Clin N Am. 2017 May;27(2):251-265. doi: 10.1016/j.nic.2016.12.010. Epub 2017 Feb 9. Review.

PMID:
28391784
41.

Whole brain and grey matter volume of Japanese patients with multiple sclerosis.

Akaishi T, Nakashima I, Mugikura S, Aoki M, Fujihara K.

J Neuroimmunol. 2017 May 15;306:68-75. doi: 10.1016/j.jneuroim.2017.03.009. Epub 2017 Mar 16.

PMID:
28385190
42.

Bilateral frontal cortex encephalitis and paraparesis in a patient with anti-MOG antibodies.

Fujimori J, Takai Y, Nakashima I, Sato DK, Takahashi T, Kaneko K, Nishiyama S, Watanabe M, Tanji H, Kobayashi M, Misu T, Aoki M, Fujihara K.

J Neurol Neurosurg Psychiatry. 2017 Jun;88(6):534-536. doi: 10.1136/jnnp-2016-315094. Epub 2017 Feb 16. No abstract available.

PMID:
28209651
43.

Impact of the anti-aquaporin-4 autoantibody on inner retinal structure, function and structure-function associations in Japanese patients with optic neuritis.

Matsumoto Y, Mori S, Ueda K, Kurimoto T, Kanamori A, Yamada Y, Nakashima I, Nakamura M.

PLoS One. 2017 Feb 15;12(2):e0171880. doi: 10.1371/journal.pone.0171880. eCollection 2017.

44.

A case of very long longitudinally extensive transverse myelitis (LETM) with necrotizing Vasculitis.

Sato K, Tsunoda K, Yamashita T, Takemoto M, Hishikawa N, Ohta Y, Takahashi T, Nakashima I, Yasuhara T, Date I, Abe K.

J Neurol Sci. 2017 Feb 15;373:152-154. doi: 10.1016/j.jns.2016.12.040. Epub 2016 Dec 23. No abstract available.

PMID:
28131176
45.

MOG antibody-positive, benign, unilateral, cerebral cortical encephalitis with epilepsy.

Ogawa R, Nakashima I, Takahashi T, Kaneko K, Akaishi T, Takai Y, Sato DK, Nishiyama S, Misu T, Kuroda H, Aoki M, Fujihara K.

Neurol Neuroimmunol Neuroinflamm. 2017 Jan 16;4(2):e322. doi: 10.1212/NXI.0000000000000322. eCollection 2017 Mar.

46.

Sporadic Inclusion Body Myositis Manifesting as Isolated Muscle Weakness of the Finger Flexors Three Years after Disease Onset.

Suwa Y, Suzuki N, Soga T, Harada R, Shibui A, Kuroda H, Izumi R, Tateyama M, Nakashima I, Sonoo M, Aoki M.

Intern Med. 2016;55(23):3521-3524. Epub 2016 Dec 1.

47.

Hypoxia-like tissue injury and glial response contribute to Balo concentric lesion development.

Takai Y, Misu T, Nishiyama S, Ono H, Kuroda H, Nakashima I, Saito R, Kanamori M, Sonoda Y, Kumabe T, Mugikura S, Watanabe M, Aoki M, Fujihara K.

Neurology. 2016 Nov 8;87(19):2000-2005. Epub 2016 Oct 12.

48.

Intractable Hiccup in Demyelinating Disease with Anti-Myelin Oligodendrocyte Glycoprotein (MOG) Antibody.

Akaishi T, Konno M, Nakashima I, Aoki M.

Intern Med. 2016;55(19):2905-2906. Epub 2016 Oct 1. No abstract available.

49.

Different etiologies and prognoses of optic neuritis in demyelinating diseases.

Akaishi T, Nakashima I, Takeshita T, Kaneko K, Mugikura S, Sato DK, Takahashi T, Nakazawa T, Aoki M, Fujihara K.

J Neuroimmunol. 2016 Oct 15;299:152-157. doi: 10.1016/j.jneuroim.2016.09.007. Epub 2016 Sep 14.

PMID:
27725114
50.

Neuromyelitis optica spectrum disorders in children and adolescents.

Tenembaum S, Chitnis T, Nakashima I, Collongues N, McKeon A, Levy M, Rostasy K.

Neurology. 2016 Aug 30;87(9 Suppl 2):S59-66. doi: 10.1212/WNL.0000000000002824. Review.

PMID:
27572863

Supplemental Content

Loading ...
Support Center